查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1944398

全球ENFit注射器市场：按註射器规格、针头类型、用途、材料、分销管道、应用、病患小组、最终用户、国家和地区划分－产业分析、市场规模、份额及预测（2024-2032年）

ENFit Syringes Market, By Syringe Size, By Tip Type, By Usage Type, By Material Type, By Distribution Channel, By Application, By Patient Group, By End User, By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 341 Pages | 商品交期: 2-3个工作天内

价格
简介目录

ENFit 注射器市场规模预计到 2024 年将达到 7.981 亿美元，从 2025 年到 2032 年将以 6.77% 的复合年增长率成长。

ENFit注射器是专为经肠营养而设计的专用注射器，采用标准化的非鲁尔接头，可防止经肠营养系统、静脉注射系统和其他医疗输送系统之间的误连接。这些装置支援在新生儿、儿童和成人护理环境中透过饲管安全地输注营养液、水和药物。现代ENFit注射器注重患者安全、符合法规要求、剂量精准、与经肠营养系统的兼容性以及易用性。全球病患安全标准、医院安全通讯协定、经肠营养的日益普及、接头标准化的监管要求以及医疗环境中预防用药错误的意识不断提高，都推动了ENFit注射器的市场成长。

ENFit注射器市场动态

病人安全要求、监管标准化和预防误接推动了市场需求。

日益增长的病人安全问题正在加速ENFit注射器的普及，这种注射器可有效防止经肠营养连接错误。联合委员会发布的一份重大事件警报报告显示，与传统连接器相关的100多起管路连接错误和21例死亡病例凸显了问题的严重性。此外，一项已发表的关于连接错误事件的研究发现，2011年至2023年间共发生96起此类事件，其中4%导致死亡，69%导致患者伤害，这凸显了标准化经肠营养营养系统的必要性。 ISO 80369-3连接器标准的全球推广要求医疗机构过渡到符合ENFit标准的注射器，进一步推动了监管主导的市场成长。美国食品药物管理局（FDA）已正式认可使用不相容的肠内营养连接器来减少用药错误。此外，世界卫生组织（WHO）已将用药错误列为医疗保健领域可避免伤害的首要原因，促使各组织更加重视更安全的给药系统。医院认证要求的提高和病人安全审核的加强也加速了从传统肠内连接器向 ENFit 系统的过渡。

ENFit注射器市场：細項分析

全球 ENFit 注射器市场已根据注射器尺寸、针头类型、用途、材料、分销管道、应用、病患小组、最终用户和地区进行细分。

注射器容量分为 0.5 mL 至 1 mL、3 mL 至 5 mL、6 mL 至 10 mL、20 mL 至 35 mL、60 mL 及以上以及其他容量。较小容量的注射器，例如 0.5 mL 至 1 mL 和 3 mL 至 5 mL，主要用于新生儿和儿童经肠营养护理中的精确给药和小容量冲洗。中等容量的注射器，例如 6-10 mL 和 20-35 mL，广泛用于成人临床环境中的常规经肠营养和给药。这符合世界卫生组织 (WHO) 制定的标准经肠营养通讯协定，该方案强调精确给药对患者安全至关重要。较大容量的注射器，即 60 mL 及以上，通常用于大容量灌注和营养液大剂量投药，尤其是在采用大量餵食的长期照护机构。 「其他」类别包括在特殊临床环境中使用的特殊和非标准容量的注射器。

根据应用领域，市场可分为给药、灌注、营养输注、取样和其他用途。在给药方面，ENFit 注射器用于确保与静脉输液管路的兼容性。这直接有助于落实美国食品药物管理局(FDA) 所倡导的旨在减少肠内营养误接的安全措施。灌注是指清洁经肠营养管路以保持其通畅并防止堵塞的过程，这是临床经肠营养指南中推荐的方法。营养输注是指输注经肠营养，这是符合美国国家临床营养学会所引用的医院经肠营养通讯协定的核心应用场景。取样是指采集胃或肠道内容物以进行诊断评估。 「其他」类别包括辅助用途，例如为影像诊断程序和临床检查造影剂。

ENFit注射器市场－区域分析

全球肠内营养注射器市场呈现出显着的区域差异，这主要受多种因素影响，例如非传染性疾病（通常需要经肠营养支持）的负担、医疗基础设施的成熟度以及监管机构对患者安全日益增长的关注。世界卫生组织（世卫组织）指出，2021年全球至少75%的非流行性死亡病例将由非传染性疾病（NCDs）导致，凸显了不同医疗机构对临床营养及相关肠内营养设备的广泛需求。

在北美，先进的临床营养计画、广泛的经肠营养通讯协定以及完善的医院基础设施推动了市场发展，这些都为标准化经肠营养设备的普及提供了支持。在欧洲，全民健保政策和全面的病人安全法规促进了符合安全标准的经肠营养系统的广泛应用。在亚太地区，医疗保健覆盖范围的扩大和慢性病患病率的上升推动了对肠内注射器的需求；而拉丁美洲和中东及非洲地区则受益于政府主导的医疗保健改善以及人们对营养支持的日益重视，市场呈现稳步增长。区域市场趋势反映了全球各地医疗保健系统能力、疾病负担以及对安全使用医疗设备的政策重视程度的差异。

美国ENFit注射器市场—国家分析

美国凭藉其先进的医疗基础设施、对病人安全的高度重视以及经肠营养通讯协定的广泛应用，在全球肠内营养注射器（ENFit注射器）市场中占据领先地位。市场数据显示，到2025年，美国ENFit注射器市场规模将达到2.2609亿美元，这反映了其市场主导地位和对相关标准的早期采纳。美国医疗体系对安全用药和营养输送的重视，以及支持ENFit实施的积极临床指南，促使ENFit注射器在医院、长期照护机构和居家医疗服务机构中得到广泛应用。这些因素共同巩固了美国作为全球领先的ENFit注射器国内市场的地位。

目录

第一章 ENFit注射器市场概览

  • 分析范围
  • 市场估算期

第二章执行摘要

  • 市场区隔
  • 竞争考察

第三章 ENFit注射器的主要市场趋势

  • 市场驱动因素
  • 市场限制
  • 市场机会
  • 未来市场趋势

第四章 ENFit注射器市场：产业分析

  • PEST分析
  • 波特五力分析
  • 市场成长展望：概览
  • 管理体制分析

第五章 ENFit注射器市场：地缘政治紧张局势加剧的影响

  • 新冠疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章 ENFit注射器市场概况

  • ENFit注射器市占率分析（2024年）
  • 主要製造商的细分数据
    • 对现有公司的分析
    • 新兴企业分析

7. 按註射器尺寸分類的ENFit注射器市场

  • 概述
    • 细分市场占有率分析：按註射器规格
      • 0.5 mL-1 mL
      • 3 mL～5 mL
      • 6 mL～10 mL
      • 20mL～35mL
      • 60毫升或更多
      • 其他的

第八章 ENFit 注射器市场（按针头类型划分）

  • 概述
    • 细分市场占有率分析：按小费类型
    • ENFit 注射器，附标准针头
    • ENFit 低剂量针头注射器 (LDT)
    • 其他（例如，导管尖端变体）

9. ENFit注射器市场（依用途划分）

  • 概述
    • 细分市场占有率分析：依使用情况
    • 可重复使用的 ENFit 注射器
    • 一次性 ENFit 注射器

第十章 ENFit注射器市场（依材料分类）

  • 概述
    • 细分市场占有率分析：依材料划分
    • 聚丙烯（PP）
    • 硅酮
    • 聚乙烯（PE）
    • 其他（例如玻璃、不含PVC的聚合物）

第十一章 ENFit注射器市场（依分销管道划分）

  • 概述
    • 细分市场占有率分析：按分销管道划分
    • 医院药房
    • 网路药房
    • 零售药房
    • 直接竞标
    • 其他的

第十二章 ENFit 注射器市场依应用领域划分

  • 概述
    • 细分市场占有率分析：按应用
    • 药物管理
    • 打扫
    • 营养补充
    • 取样
    • 其他的

13. 按病患小组的ENFit注射器市场

  • 概述
    • 细分市场占有率分析：按病患小组划分
    • 老年人
    • 成人
    • 新生儿和儿童

第十四章 ENFit注射器市场（依最终用户划分）

  • 概述
    • 细分市场占有率分析：依使用情况
    • 医院
    • 长期照护机构
    • 居家医疗
    • 復健中心
    • 诊所及门诊手术中心
    • 其他的

第十五章 ENFit注射器市场（按地区划分）

  • 介绍
  • 北美洲
    • 概述
    • 北美主要製造商
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲主要製造商
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 其他的
  • 亚太地区
    • 概述
    • 亚太地区主要製造商
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 其他的
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 其他的
  • 中东和非洲
    • 概述
    • 中东和非洲的主要製造商
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • 其他的

第十六章 主要供应商分析－ENFit注射器产业

  • 竞争对手仪錶板
    • 竞争基准
    • 竞争定位
  • 公司简介
    • Becton Dickinson and Company
    • Braun Melsungen
    • Baxter International
    • Cardinal Health
    • Avanos Medical
    • Medline Industries
    • Fresenius Kabi
    • HMC Group
    • Vygon
    • Medicina
    • Vesco Medical
    • GBUK Group
    • Amsino International
    • KB Medical Group
    • Kentec Medical
    • Others

第十七章：分析师视角360度分析

简介目录
Product Code: ANV5987

ENFit syringes market size was valued at US$ 798.10 Million in 2024, expanding at a CAGR of 6.77% from 2025 to 2032.

ENFit syringes are specialized enteral feeding syringes designed with standardized, non-Luer connectors to prevent misconnections between enteral, intravenous, and other medical delivery systems. These devices support safe administration of nutrition, hydration, and medications via feeding tubes across neonatal, pediatric, and adult care settings. Modern ENFit syringes emphasize patient safety, regulatory compliance, dosing accuracy, compatibility with enteral feeding systems, and ease of use. Market opportunities are driven by global patient safety standards, hospital safety protocols, rising enteral nutrition adoption, regulatory mandates for connector standardization, and growing awareness of medication error prevention in healthcare environments.

ENFit Syringes Market- Market Dynamics

Patient safety mandates, regulatory standardization, and misconnection prevention to propel market demand

Rising patient safety concerns are accelerating adoption of ENFit syringes to prevent enteral misconnections. A Joint Commission sentinel event alert reported over 100 tubing misconnection errors and 21 deaths linked to legacy connectors, highlighting the severity of the issue. Additionally, a review of published misconnection incidents found that 96 cases occurred between 2011 and 2023, with 4% resulting in death and 69% causing patient harm, underscoring the need for standardized enteral delivery systems. The global implementation of the ISO 80369-3 connector standard mandates healthcare facilities to transition to ENFit-compliant syringes, reinforcing regulatory-driven market growth. The U.S. Food and Drug Administration (FDA) has formally supported adoption of incompatible enteral connectors to reduce medication administration errors. Furthermore, the World Health Organization (WHO) identifies medication errors as a leading cause of avoidable harm in healthcare, strengthening institutional emphasis on safer delivery systems. Increasing hospital accreditation requirements and patient safety audits are also accelerating conversion from legacy enteral connectors to ENFit systems.

ENFit Syringes Market- Segmentation Analysis:

The Global ENFit Syringes Market is segmented on the basis of Syringe Size, Tip Type, Usage Type, Material Type, Distribution Channel, Application, Patient Group, End User, and Region.

Based on Syringe Size, the market is categorized into 0.5 mL-1 mL, 3 mL-5 mL, 6 mL-10 mL, 20 mL-35 mL, 60 mL and above, and Others. Smaller sizes, such as 0.5-1 mL and 3-5 mL, are predominantly used for precise delivery of medications and small-volume flushing in neonatal and pediatric enteral care. Mid-range volumes like 6-10 mL and 20-35 mL are commonly employed for routine enteral nutrition and medication administration in adult clinical settings, aligning with standard enteral feeding protocols detailed by the World Health Organization (WHO), which emphasizes accurate dosing as critical to patient safety. Larger syringes of 60 mL and above are typically used for high-volume flushing and nutrition bolus delivery, especially in long-term care facilities where batch feeding is practiced. The "Others" category accommodates specialized or non-standard sizes used in niche clinical settings.

Based on the application, the market is divided into Medication Delivery, Flushing, Nutrition Delivery, Sampling, and Others. Medication Delivery leverages ENFit syringes to ensure incompatibility with intravenous lines, directly supporting safety initiatives promoted by organizations like the U.S. Food and Drug Administration (FDA) to reduce enteral misconnections. Flushing applications involve clearing enteral feeding tubes to maintain patency and prevent blockages, a practice endorsed in clinical enteral feeding guidelines. Nutrition Delivery represents the administration of enteral nutrition formulas, a core use case aligned with hospital enteral nutrition protocols as referenced by national clinical nutrition associations. Sampling captures the withdrawal of gastric or intestinal contents for diagnostic assessment. The "Others" segment includes ancillary uses such as contrast agent delivery for imaging procedures or clinical research applications.

ENFit Syringes Market- Geographical Insights

The global ENFit syringes market exhibits notable regional variation influenced by the burden of noncommunicable diseases (which often require enteral nutrition support), healthcare infrastructure maturity, and regulatory emphasis on patient safety. According to the World Health Organization (WHO), noncommunicable diseases (NCDs) accounted for at least 75% of all non-pandemic deaths globally in 2021, highlighting the widespread demand for clinical nutrition and related enteral devices in diverse healthcare settings.

North America demonstrates strong market strength due to advanced clinical nutrition programs, extensive enteral feeding protocols, and well-established hospital infrastructures that support standardized enteral device adoption. Europe follows with significant adoption of safety-compliant enteral feeding systems supported by universal healthcare policies and comprehensive patient safety regulations. In Asia-Pacific, expanding healthcare access and rising chronic disease prevalence are driving demand for enteral syringes, while Latin America and the Middle East & Africa show steady growth as government-led healthcare improvements and nutrition support awareness expand. The regional market performance reflects differing healthcare system capacities, disease burdens, and policy emphases on safe medical device utilization across global regions.

U.S. ENFit Syringes Market-Country Insights

The United States leads the global ENFit syringes market, driven by advanced healthcare infrastructure, high awareness of patient safety, and widespread adoption of enteral feeding protocols. According to market data, the U.S. ENFit syringes segment recorded a market size of USD 226.09 million in 2025, reflecting its dominant position and early standard adoption. The U.S. healthcare system's focus on safe medication and nutrition delivery, combined with proactive clinical guidelines supporting ENFit implementation, sustains high adoption rates across hospitals, long-term care facilities, and homecare services. These factors collectively reinforce the United States as the leading national market for ENFit syringes globally.

ENFit Syringes Market- Competitive Landscape:

The global ENFit syringes market is competitive and characterized by the presence of several established multinational medical device manufacturers alongside regional and specialized producers. Key players include Becton Dickinson and Company, Braun Melsungen, Baxter International, Cardinal Health, Avanos Medical, Medline Industries, Fresenius Kabi, and others. These players are contributing to market dynamics by expanding ENFit-compliant product portfolios and engaging in strategic partnerships or supply agreements. Market competition is driven by innovations in syringe design, customization for clinical needs, and enhanced safety features to support enteral feeding protocols compliant with ISO 80369-3 standards. Companies are increasingly focusing on broadening their geographic reach, strengthening distribution networks in hospitals and home healthcare channels, and investing in R&D to improve ergonomic and infection-control characteristics of ENFit syringes.

Recent Developments:

In January 2026, ENvue Medical launched a new line of over-the-counter reusable ENFit syringes for enteral feeding and medication delivery that meet ISO 80369-3 standards. Available in multiple sizes without a prescription, these syringes aim to improve safety and continuity of care for patients in clinical and home settings.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ENFIT SYRINGES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Becton Dickinson and Company
  • Braun Melsungen
  • Baxter International
  • Cardinal Health
  • Avanos Medical
  • Medline Industries
  • Fresenius Kabi
  • HMC Group
  • Vygon
  • Medicina
  • Vesco Medical
  • GBUK Group
  • Amsino International
  • KB Medical Group
  • Kentec Medical
  • Others

GLOBAL ENFIT SYRINGES MARKET, BY SYRINGE SIZE- MARKET ANALYSIS, 2019 - 2032

  • 0.5 mL - 1 mL
  • 3 mL - 5 mL
  • 6 mL - 10 mL
  • 20 mL - 35 mL
  • 60 mL and above
  • Others

GLOBAL ENFIT SYRINGES MARKET, BY TIP TYPE- MARKET ANALYSIS, 2019 - 2032

  • Standard Tip ENFit Syringes
  • Low Dose Tip (LDT) ENFit Syringes
  • Others (e.g., catheter tip variants)

GLOBAL ENFIT SYRINGES MARKET, BY USAGE TYPE- MARKET ANALYSIS, 2019 - 2032

  • Reusable ENFit Syringes
  • Disposable ENFit Syringes

GLOBAL ENFIT SYRINGES MARKET, BY MATERIAL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Polypropylene (PP)
  • Silicone
  • Polyethylene (PE)
  • Others (e.g., Glass, PVC-free polymers)

GLOBAL ENFIT SYRINGES MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2019 - 2032

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Direct Tenders
  • Others

GLOBAL ENFIT SYRINGES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Medication Delivery
  • Flushing
  • Nutrition Delivery
  • Sampling
  • Others

GLOBAL ENFIT SYRINGES MARKET, BY PATIENT GROUP- MARKET ANALYSIS, 2019 - 2032

  • Geriatric
  • Adults
  • Neonates & Pediatric

GLOBAL ENFIT SYRINGES MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Long-Term Care Facilities
  • Home Healthcare Settings
  • Rehabilitation Centers
  • Clinics & Ambulatory Surgical Centers
  • Others

GLOBAL ENFIT SYRINGES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. ENFit Syringes Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. ENFit Syringes Key Market Trends

  • 3.1. ENFit Syringes Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. ENFit Syringes Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. ENFit Syringes Market Opportunities
  • 3.4. ENFit Syringes Market Future Trends

4. ENFit Syringes Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ENFit Syringes Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. ENFit Syringes Market Landscape

  • 6.1. ENFit Syringes Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. ENFit Syringes Market - By Syringe Size

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Syringe Size, 2024 & 2032 (%)
      • 7.1.1.1. 0.5 mL - 1 mL
      • 7.1.1.2. 3 mL - 5 mL
      • 7.1.1.3. 6 mL - 10 mL
      • 7.1.1.4. 20 mL - 35 mL
      • 7.1.1.5. 60 mL and above
      • 7.1.1.6. Others

8. ENFit Syringes Market - By Tip Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Tip Type, 2024 & 2032 (%)
    • 8.1.2. Standard Tip ENFit Syringes
    • 8.1.3. Low Dose Tip (LDT) ENFit Syringes
    • 8.1.4. Others (e.g., catheter tip variants)

9. ENFit Syringes Market - By Usage Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Usage Type, 2024 & 2032 (%)
    • 9.1.2. Reusable ENFit Syringes
    • 9.1.3. Disposable ENFit Syringes

10. ENFit Syringes Market - By Material Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Material Type, 2024 & 2032 (%)
    • 10.1.2. Polypropylene (PP)
    • 10.1.3. Silicone
    • 10.1.4. Polyethylene (PE)
    • 10.1.5. Others (e.g., Glass, PVC-free polymers)

11. ENFit Syringes Market - By Distribution Channel

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By Distribution Channel, 2024 & 2032 (%)
    • 11.1.2. Hospital Pharmacies
    • 11.1.3. Online Pharmacies
    • 11.1.4. Retail Pharmacies
    • 11.1.5. Direct Tenders
    • 11.1.6. Others

12. ENFit Syringes Market - By Application

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 12.1.2. Medication Delivery
    • 12.1.3. Flushing
    • 12.1.4. Nutrition Delivery
    • 12.1.5. Sampling
    • 12.1.6. Others

13. ENFit Syringes Market - By Patient Group

  • 13.1. Overview
    • 13.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 13.1.2. Geriatric
    • 13.1.3. Adults
    • 13.1.4. Neonates & Pediatric

14. ENFit Syringes Market - By End User

  • 14.1. Overview
    • 14.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 14.1.2. Hospitals
    • 14.1.3. Long-Term Care Facilities
    • 14.1.4. Home Healthcare Settings
    • 14.1.5. Rehabilitation Centers
    • 14.1.6. Clinics & Ambulatory Surgical Centers
    • 14.1.7. Others

15. ENFit Syringes Market- By Geography

  • 15.1. Introduction
    • 15.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 15.2. North America
    • 15.2.1. Overview
    • 15.2.2. ENFit Syringes Key Manufacturers in North America
    • 15.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 15.2.4. North America Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
    • 15.2.5. North America Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
    • 15.2.6. North America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 15.2.7. North America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 15.2.8. North America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 15.2.9. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 15.2.10. North America Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
    • 15.2.11. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 15.2.12. U.S.
    • 15.2.13. Canada
  • 15.3. Europe
    • 15.3.1. Overview
    • 15.3.2. ENFit Syringes Key Manufacturers in Europe
    • 15.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 15.3.4. Europe Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
    • 15.3.5. Europe Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
    • 15.3.6. Europe Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 15.3.7. Europe Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 15.3.8. Europe Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 15.3.9. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 15.3.10. Europe Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
    • 15.3.11. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 15.3.12. Germany
    • 15.3.13. UK
    • 15.3.14. France
    • 15.3.15. Italy
    • 15.3.16. Spain
    • 15.3.17. The Netherlands
    • 15.3.18. Sweden
    • 15.3.19. Russia
    • 15.3.20. Poland
    • 15.3.21. Rest of Europe
  • 15.4. Asia Pacific (APAC)
    • 15.4.1. Overview
    • 15.4.2. ENFit Syringes Key Manufacturers in Asia Pacific
    • 15.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 15.4.4. Asia Pacific Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
    • 15.4.5. Asia Pacific Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
    • 15.4.6. Asia Pacific Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 15.4.7. Asia Pacific Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 15.4.8. Asia Pacific Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 15.4.9. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 15.4.10. Asia Pacific Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
    • 15.4.11. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 15.4.12. China
    • 15.4.13. India
    • 15.4.14. Japan
    • 15.4.15. South Korea
    • 15.4.16. Australia
    • 15.4.17. Indonesia
    • 15.4.18. Thailand
    • 15.4.19. Philippines
    • 15.4.20. Rest of Asia Pacific
  • 15.5. Latin America
    • 15.5.1. Overview
    • 15.5.2. ENFit Syringes Key Manufacturers in Latin America
    • 15.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 15.5.4. Latin America Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
    • 15.5.5. Latin America Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
    • 15.5.6. Latin America Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 15.5.7. Latin America Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 15.5.8. Latin America Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 15.5.9. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 15.5.10. Latin America Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
    • 15.5.11. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 15.5.12. Brazil
    • 15.5.13. Mexico
    • 15.5.14. Argentina
    • 15.5.15. Columbia
    • 15.5.16. Rest of Latin America
  • 15.6. Middle East and Africa
    • 15.6.1. Overview
    • 15.6.2. ENFit Syringes Key Manufacturers in Middle East and Africa
    • 15.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 15.6.4. Middle East and Africa Market Size and Forecast, By Syringe Size, 2019 - 2032 (US$ Million)
    • 15.6.5. Middle East and Africa Market Size and Forecast, By Tip Type, 2019 - 2032 (US$ Million)
    • 15.6.6. Middle East and Africa Market Size and Forecast, By Usage Type, 2019 - 2032 (US$ Million)
    • 15.6.7. Middle East and Africa Market Size and Forecast, By Material Type, 2019 - 2032 (US$ Million)
    • 15.6.8. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2019 - 2032 (US$ Million)
    • 15.6.9. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 15.6.10. Middle East and Africa Market Size and Forecast, By Patient Group, 2019 - 2032 (US$ Million)
    • 15.6.11. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 15.6.12. Saudi Arabia
    • 15.6.13. UAE
    • 15.6.14. Israel
    • 15.6.15. Turkey
    • 15.6.16. Algeria
    • 15.6.17. Egypt
    • 15.6.18. Rest of Middle East and Africa

16. Key Vendor Analysis- ENFit Syringes Industry

  • 16.1. Competitive Dashboard
    • 16.1.1. Competitive Benchmarking
    • 16.1.2. Competitive Positioning
  • 16.2. Company Profiles
    • 16.2.1. Becton Dickinson and Company
    • 16.2.2. Braun Melsungen
    • 16.2.3. Baxter International
    • 16.2.4. Cardinal Health
    • 16.2.5. Avanos Medical
    • 16.2.6. Medline Industries
    • 16.2.7. Fresenius Kabi
    • 16.2.8. HMC Group
    • 16.2.9. Vygon
    • 16.2.10. Medicina
    • 16.2.11. Vesco Medical
    • 16.2.12. GBUK Group
    • 16.2.13. Amsino International
    • 16.2.14. KB Medical Group
    • 16.2.15. Kentec Medical
    • 16.2.16. Others

17. 360 Degree Analyst View

18. Appendix

  • 18.1. Research Methodology
  • 18.2. References
  • 18.3. Abbreviations
  • 18.4. Disclaimer
  • 18.5. Contact Us